30 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
, revolution, hostile act, civil strife, pandemic, cyberattack or similar event; or
(l) any other circumstance which might otherwise constitute a legal
424B3
1j1quxqq
14 Aug 23
Prospectus supplement
4:30pm
S-4/A
3iw xwuisf
26 Jun 23
Registration of securities issued in business combination transactions (amended)
5:02pm
S-4
nv5udlq168n066ph
15 May 23
Registration of securities issued in business combination transactions
3:02pm
425
EX-2.1
pcceotw978n
17 Apr 23
Business combination disclosure
6:02am
8-K
EX-2.1
49k3buvs9u
17 Apr 23
Entry into a Material Definitive Agreement
6:01am